Trial Profile
Switching test from cinalcalcet to etelcalcetide in secondary hyperpapathyroidism patients ongoing hemodialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2018
Price :
$35
*
At a glance
- Drugs Etelcalcetide (Primary) ; Cinacalcet
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 06 Aug 2018 New trial record